Centering racial justice for Black/African American and Indigenous American people in commercial tobacco product regulation

• DOI: 10.1016/j.ypmed.2022.107117
• Publication Date: 2022-06-15T15:18:20Z
• Authors: Alison B. Breland; Dana Carroll; Rachel Denlinger-...; Jennifer Cornacch...; Claradina Soto; Cassidy White; Eric C. Donny; Pebbles Fagan; Phillip Gardiner; Thomas Eissenberg; Mignonne C. Guy
• Keywords: Black or African American; Nicotiana; Racism; 0504 sociology; Social Justice; 05 social sciences; Humans; Tobacco Products; 10. No inequality; United States; 3. Good health

Although overall health in the United States (US) has improved dramatically during the past century, long-standing health inequities, particularly the unequal and unjust burden of tobacco-related disease and death among racialized populations, persist. A considerable gap exists in our understanding of how commercial tobacco product regulations and policies cause and/or exacerbate race-based health inequities among Black/African American (B/AA) and Indigenous American people. The purpose of this paper is to 1) describe how existing US commercial tobacco regulatory policies may contribute to structural racism and undermine the full benefits of tobacco prevention and control efforts among B/AA and Indigenous American groups; and 2) initiate a call to action for researchers and regulators of tobacco products to examine policies using an equity lens. These actions are imperative if empirically-informed regulation of commercial tobacco products is to address health equity.